<p>Summary statistics of the levodopa equivalent daily dose (LEDD) and natural logarithm LEDD (Ln LEDD) at baseline.</p
<p>The first two data columns provide the correlation values per parameter in each group. The last c...
<p>Summary table of the clinical characteristics of the LGMD2I cohort (n = 38).</p
<p>Clinical statistics of the time frame of ALS-like symptoms with corresponding treatment doses.</p
<p>Spearman's Correlation Between Levodopa Equivalent Dose (LED) Change From Baseline to 1-year Comp...
Interpretation of clinical trials comparing different drug regimens for Parkinson's disease (PD) is ...
<p>Correlations between concentrations of selected amino acids (μmol/l) and levodopa equivalent dose...
<p>Box Plot: Natural logarithm of levodopa equivalent daily dose displayed by sex.</p
<p>Levodopa equivalent dose (LED), motor (UPDRS-II and III in on and off phase), cognitive (MMSE and...
<p>Levodopa equivalent dosage in PD patients with and without premotor symptoms.</p
<p>*UPDRS motor +ADL scores were divided by 10 to visualize the regression coefficient.</p><p>Model ...
<p>The daily levodopa dose is indicated on the abscissa, the number of neurographically impaired ner...
<p>UPDRS-III; Unified Parkinson's Disease Rating Scale part III. LED; levodopa-equivalent dose.</p
<p>UPDRS-III; Unified Parkinson's Disease Rating Scale part III. LED; levodopa-equivalent dose.</p
<p>The sum of each of the test statistics across all of the SNPs in each of the diseases. LTPub vs L...
<p>HNM-PD (closed circle) received higher levodopa-equivalent dose than LNM-PD (open circle) at simi...
<p>The first two data columns provide the correlation values per parameter in each group. The last c...
<p>Summary table of the clinical characteristics of the LGMD2I cohort (n = 38).</p
<p>Clinical statistics of the time frame of ALS-like symptoms with corresponding treatment doses.</p
<p>Spearman's Correlation Between Levodopa Equivalent Dose (LED) Change From Baseline to 1-year Comp...
Interpretation of clinical trials comparing different drug regimens for Parkinson's disease (PD) is ...
<p>Correlations between concentrations of selected amino acids (μmol/l) and levodopa equivalent dose...
<p>Box Plot: Natural logarithm of levodopa equivalent daily dose displayed by sex.</p
<p>Levodopa equivalent dose (LED), motor (UPDRS-II and III in on and off phase), cognitive (MMSE and...
<p>Levodopa equivalent dosage in PD patients with and without premotor symptoms.</p
<p>*UPDRS motor +ADL scores were divided by 10 to visualize the regression coefficient.</p><p>Model ...
<p>The daily levodopa dose is indicated on the abscissa, the number of neurographically impaired ner...
<p>UPDRS-III; Unified Parkinson's Disease Rating Scale part III. LED; levodopa-equivalent dose.</p
<p>UPDRS-III; Unified Parkinson's Disease Rating Scale part III. LED; levodopa-equivalent dose.</p
<p>The sum of each of the test statistics across all of the SNPs in each of the diseases. LTPub vs L...
<p>HNM-PD (closed circle) received higher levodopa-equivalent dose than LNM-PD (open circle) at simi...
<p>The first two data columns provide the correlation values per parameter in each group. The last c...
<p>Summary table of the clinical characteristics of the LGMD2I cohort (n = 38).</p
<p>Clinical statistics of the time frame of ALS-like symptoms with corresponding treatment doses.</p